![]() |
Volumn 8, Issue 9, 2013, Pages
|
The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HERMES ANTIGEN;
HYALURONAN MEDIATED MOTILITY RECEPTOR;
HYALURONAN-MEDIATED MOTILITY RECEPTOR;
HYALURONIC ACID;
MESSENGER RNA;
SCLEROPROTEIN;
AGED;
ANIMAL;
APOPTOSIS;
ARTICLE;
BLADDER TUMOR;
CANCER GRADING;
CANCER STAGING;
DISEASE COURSE;
DISEASE MODEL;
FEMALE;
GENE SILENCING;
GENETICS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
MOUSE;
PATHOLOGY;
PHENOTYPE;
PROGNOSIS;
RISK FACTOR;
TRANSITIONAL CELL CARCINOMA;
TUMOR VOLUME;
VERY ELDERLY;
XENOGRAFT;
AGED;
AGED, 80 AND OVER;
ANIMALS;
ANTIGENS, CD44;
APOPTOSIS;
CARCINOMA, TRANSITIONAL CELL;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
EXTRACELLULAR MATRIX PROTEINS;
FEMALE;
GENE KNOCKDOWN TECHNIQUES;
HETEROGRAFTS;
HUMANS;
HYALURONIC ACID;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
MALE;
MICE;
MIDDLE AGED;
NEOPLASM GRADING;
NEOPLASM STAGING;
PHENOTYPE;
PROGNOSIS;
RISK FACTORS;
RNA, MESSENGER;
TUMOR BURDEN;
URINARY BLADDER NEOPLASMS;
|
EID: 84892422200
PISSN: None
EISSN: 19326203
Source Type: Journal
DOI: 10.1371/journal.pone.0075681 Document Type: Article |
Times cited : (35)
|
References (0)
|